June 6, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re: | NovaBay Pharmaceuticals, Inc. (the “Company”) Form S-1, File No. 33-272297 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1, as amended, to become effective as of 5:00 p.m. (Eastern time) on Thursday, June 8, 2023, or as soon as practicable thereafter.
Very truly yours, | ||
NovaBay Pharmaceuticals, Inc. | ||
By: | /s/ Justin Hall | |
Justin Hall | ||
Chief Executive Officer and General Counsel | ||
cc: Abby E. Brown, Squire Patton Boggs (US) LLP
